Capricorn Partners seeks EUR 25m for industrial biotech VC fund
Belgian VC investor Capricorn Partners is open to more investor approaches for its new industrial biotech fund as it aims for a final close on EUR 25m by the end of next year, partner Rob van der Meij told Unquote.
More on Venture
InnovaFonds gears up for first close of new SME fund
French GP’s mezzanine and small equity tickets vehicle aims to attract institutional investors and has a EUR 100m target
Presto Ventures targets EUR 100m for new early-stage fund
Czech VC seeks to attract larger institutional investors from Western Europe and US for its third vehicle
Merito Partners targets EUR 50m for debut growth equity fund
Sponsor plans to build a portfolio of 12-18 companies, with EUR 12m in fund commitments secured to date
Series A rounds likely bright spots in VC investing in Q1 2023 – KPMG
Energy security, ESG deals to continue apace, with consumer-focused businesses seeing most strain
Latest News
21 Invest France eyes EUR 300m Fund VI target by year-end
Fund VI has raised half of its target so far, with the GP seeking to further prove its investment track record throughout 2023
IPEM 2023: GPs battle fundraising blues on the Côte d'Azur
Sponsors remain broadly optimistic despite fundraise bottlenecks and a growing number of LPs faced with tough choices on manager selection
Equistone to exit Acuity in sale to Permira
Sale of financial services research group follows process with early discussions between vendor and bidders
Clessidra on track for 2023 final close for debut private debt fund
GP has raised EUR 150m for the vehicle against a EUR 250m target, with one third already deployed